Wells Fargo & Company Lexaria Bioscience Corp. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEXX
# of Institutions
28Shares Held
2.05MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$2.25 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.13 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$253,6700.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA93.6KShares$206,8250.0% of portfolio
-
Gen Trust, LLC60KShares$132,6000.01% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $13.2M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...